Markets

Market

News Details

(04/08/2026 16:38)

Zydus Lifesciences gets USFDA nod for Generic Indocyanine Green Injection

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) for its generic Indocyanine Green for Injection, 25 mg/vial, expanding its portfolio in the US market.

The approval covers the company's Abbreviated New Drug Application (ANDA) for the sterile lyophilised powder used as an optical imaging agent for fluorescence imaging.

The product is the generic equivalent of IC-Green, marketed by Diagnostic Green LLC. The USFDA has also designated the application as a Competitive Generic Therapy (CGT), a status aimed at encouraging the development of generic medicines in markets with limited competition.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.